Research Article
Effects of Qigong Therapy on the Anaerobic Threshold in Patients with Stable Coronary Artery Disease: A Randomized Controlled Trial
Table 3
Comparison of baseline demographic characteristics.
| | | Total | The QG group (n = 30) | The CON group (n = 29) | |
| | Sex (n (%)) | | Male | 17 (28.8) | 10 (33.3) | 7 (24.1) | 0.436 | | Female | 42 (71.2) | 20 (66.7) | 22 (75.9) | | | Average age (mean ± SD) (y) | 60.95 ± 5.15 | 61.23 ± 5.24 | 60.66 ± 5.85 | 0.843 | | Course of disease (mean ± SD) (y) | 4.36 ± 2.02 | 4.73 ± 2.08 | 3.97 ± 1.92 | 0.147 | | Height (mean ± SD) (cm) | 163.34 ± 6.89 | 163.5 ± 7.48 | 163.17 ± 6.34 | 0.857 | | Weight (mean ± SD) (kg) | 63.86 ± 10.01 | 63.04 ± 10.53 | 64.71 ± 9.56 | 0.527 | | BMI (mean ± SD) (kg/m2) | 23.81 ± 2.52 | 23.47 ± 2.47 | 24.17 ± 2.58 | 0.293 | | History of surgery (n (%)) | | Coronary artery bypass | 8 (13.6) | 5 (16.7) | 3 (10.3) | 0.950 | | Coronary intervention | 19 (32.2) | 11 (36.7) | 8 (27.6) | | No | 32 (20.3) | 14 (46.7) | 18 (62.1) | | Combined disease (n (%)) | | Hypertension | 51 (86.4) | 28 (93.3) | 23 (79.3) | 0.916 | | Diabetes | 12 (20.3) | 7 (23.3) | 5 (17.2) | | Dyslipidemia | 46 (78.0) | 26 (86.7) | 20 (69.0) | | Cerebrovascular disease | 8 (13.6) | 3 (10.0) | 5 (17.2) | | Smoking | 33 (56.0) | 18 (60.0) | 15 (51.7) | | Drinking | 30 (50.8) | 14 (46.7) | 16 (55.2) | | Sleep disorder | 38 (64.4) | 17 (56.7) | 21 (72.4) | | Psychological stress | 21 (35.6) | 11 (36.7) | 10 (34.5) | | CVD drugs (n (%)) | | Aspirin | 47 (79.7) | 26 (86.7) | 21 (72.4) | 0.936 | | Clopidogrel | 18 (30.5) | 10 (33.3) | 8 (27.6) | | ACEI | 33 (55.9) | 17 (56.7) | 16 (55.2) | | ARB | 14 (23.7) | 8 (26.7) | 6 (20.7) | | CCB | 18 (30.5) | 10 (33.3) | 8 (27.6) | | Diuretic | 6 (10.2) | 4 (13.3) | 2 (6.9) | | Statins | 35 (59.3) | 15 (50.0) | 20 (69.0) | | Oral hypoglycemic agent | 2 (28.8) | 2 (6.7) | 0 (0) | | Insulin | 3 (3.4) | 2 (6.7) | 1 (3.4) | | Others | 19 (32.2) | 10 (33.3) | 9 (31.0) |
|
|
ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium antagonist; CVD: cardio-vascular disease; QG: qigong group; CON: control group.
|
